About Us
About Us
Palisade Bio is a biopharmaceutical company focused on developing therapeutics that protect the integrity of the intestinal barrier. The Company utilizes over three decades of research and established science that links the role of intestinal barrier biology and human disease to develop novel therapeutics that target and improve the integrity of the intestinal barrier.
The Company’s lead program, LB1148, is a broad-spectrum serine protease inhibitor which acts to neutralize digestive enzymes, potentially reducing intestinal damage. In clinical studies, LB1148 has demonstrated positive results in reducing the incidence and severity of post-surgical abdominal adhesions and accelerating the time to return of postoperative bowel function. LB1148 is being investigated in a Phase 2 study to evaluate return of gastrointestinal function, post-operative ileus and intra-abdominal adhesions in subjects undergoing elective bowel resection (PROFILE).

Leadership Team
Our leadership is comprised of a team of experts in clinical development, commercialization, and pipeline development who are passionate about the advancement of science and medicine.
JD Finley
Interim Chief Executive Officer and Chief Financial Officer
Herbert B. Slade, M.D.
Chief Medical Officer
Robert McRae
Senior Vice President, Operations and Strategic Development
Nicholas McCoy
Vice President Clinical Operations
Ryker Willie
Vice President, Finance and Corporate Controller
Board Of Directors
James R. Neal
Chairman of the Board
Stephanie C. Diaz
Director
Donald A. Williams
Director
Mary Ann Gray, Ph.D.
Director
Cristina Csimma, Pharm.D., MHP
Director
Robert J. Trenschel, D.O.
Director
Binxian Wei
Director
Clinical Steering Committee
David Berry, M.D.
Clinical Steering Committee Chair
Mark Talamini, M.D.
Clinical Steering Committee Member
Jerrold Levy, M.D.
Clinical Steering Committee Member
Steven D. Wexner, M.D.
Clinical Steering Committee Member
Ronald Hurst, M.D., F.A.C.S.
Clinical Steering Committee Member
Paul A. Checchia, M.D.
Clinical Steering Committee Member
Scientific Advisory Board
Geert Schmid-Schönbein, Ph.D.
Scientific Co-Founder of Leading BioSciences, Scientific Advisory Board Member
David B. Hoyt, M.D., F.A.C.S.
Scientific Co-Founder of Leading BioSciences, Scientific Advisory Board Member
Darin Saltzman, M.D., Ph.D.
Scientific Advisory Board Member
Tim Tully, Ph.D.
Scientific Advisory Board Member
Careers
The Palisade Bio team is dedicated to developing new therapies for a range of serious, widespread health conditions that impact millions of patients every year. We are driven by science—and supported by a culture of innovation, openness and problem-solving.
Join us in our mission.